Major League Baseball and the Players Association announced the latest move to keep performance enhancers out of the game. The league, along with the MLBPA issued a release saying they have agreed to random, in season blood testing for human growth hormone (HGH) starting in the 2013 season.
The agreement also calls for the World Anti-Doping Agency (WADA) to test every player to get a baseline testosterone/epitestosterone (T/E) ratio in order to more effectively detect banned substances.
“This agreement addresses critical drug issues and symbolizes Major League Baseball’s continued vigilance against synthetic human growth hormone, Testosterone and other performance-enhancing substances,” Baseball Commissioner Bud Selig said in the statement. “I am proud that our system allows us to adapt to the many evolving issues associated with the science and technology of drug testing.”
MLBPA Executive Direction Michael Weiner added, “The Players are determined to do all they can to continually improve the sport’s Joint Drug Agreement. Players want a program that is tough, scientificially accurate, backed by the latest proven scientific methods and fair. I believe these changes firmly support the Players’ desires while protecting their legal rights.”